Skip to main content

Peer Review reports

From: TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model

Original Submission
28 Nov 2018 Submitted Original manuscript
2 Apr 2019 Author responded Author comments - Louie Semaan
21 Dec 2018 Reviewed Reviewer Report - Tze-Sing Huang
28 Dec 2018 Reviewed Reviewer Report - James J. Driscoll
Resubmission - Version 2
2 Apr 2019 Submitted Manuscript version 2
28 Jun 2019 Author responded Author comments - Louie Semaan
12 May 2019 Reviewed Reviewer Report - Tze-Sing Huang
22 Apr 2019 Reviewed Reviewer Report - James J. Driscoll
Resubmission - Version 3
28 Jun 2019 Submitted Manuscript version 3
9 Aug 2019 Author responded Author comments - Louie Semaan
Resubmission - Version 4
9 Aug 2019 Submitted Manuscript version 4
28 Aug 2019 Author responded Author comments - Louie Semaan
Resubmission - Version 5
28 Aug 2019 Submitted Manuscript version 5
16 Sep 2019 Author responded Author comments - Louie Semaan
Resubmission - Version 6
16 Sep 2019 Submitted Manuscript version 6
Publishing
20 Sep 2019 Editorially accepted
21 Oct 2019 Article published 10.1186/s12885-019-6185-0

You can find further information about peer review here.

Back to article page